Boudewijn Burgering

Full Professor

Strategic program(s):

Contact

bburgeri@umcutrecht.nl

Pure profile

Recent publications

All publications

PKP2 orchestrates OXPHOS expression in cardiomyocytes via a PGC1α-dependent mechanism Su Ji Han, Daphne van den Berg, Hesther de Ruiter, Hoyee Tsui, Eirini Kyriakopoulou, Tim Koopmans, Ilaria Perini, Jantine Monshouwer-Kloots, Sebastiaan J van Kampen, Anneline S J M Te Riele, Ilse R Kelters, Monica Gianoli, Boudewijn M T Burgering, Eva van Rooij
Cardiovascular research, 2026, vol. 122, p.2024-2038

Microbiota-derived metabolites as modulators of cancer immunotherapy response Catherine Toner-Bartelds, Iris L Mimpen, Miguel Parra-Martinez, Boudewijn M T Burgering, Emile E Voest
Nature Communications, 2026, vol. 17

The future of Forkhead box O transcription factors Huanjie Huang, Tianshu Gui, Boudewijn Mt Burgering
Biochemical Journal, 2026, vol. 483

Microbial metabolic pathways guide response to immune checkpoint blockade therapy Iris L Mimpen, Thomas W Battaglia, Miguel Parra Martinez, Catherine Toner-Bartelds, Laurien J Zeverijn, Birgit S Geurts, Karlijn Verkerk, Louisa R Hoes, Allard W J van Renterghem, Michael Noe, Ingrid Hofland, Annegien Broeks, Vincent van der Noort, Edwin C A Stigter, Can M C Gulersonmez, Boudewijn M T Burgering, Merel van Gogh, Marcel R de Zoete, Hans Gelderblom, Krijn K Dijkstra, Lodewyk F A Wessels, Emile E Voest
Cancer Discovery, 2025, vol. 16, p.95–113

Activation of a FOXO3-induced cell cycle arrest regulates ferroptosis Huanjie Huang, Matthias van Sligtenhorst, Alida M.M. Smits, Can Gulersonmez, Edwin Stigter, Tobias B. Dansen, Boudewijn M.T. Burgering
Cell death discovery, 2025, vol. 11

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI Benjamin Bourgeois, Emil Spreitzer, Daniel Platero-Rochart, Margret Paar, Qishun Zhou, Sinem Usluer, Peter L J de Keizer, Boudewijn M T Burgering, Pedro A Sánchez-Murcia, Tobias Madl
Nature Communications, 2025, vol. 16

External positions

Scientific Advisor - wetenschappelijk - Cleara Biotech B.V.

Lid ERC Starting Grant Beoordilingscommissie LS4 - - European Research Council

consultant/ PhD begeleider - wetenschappelijk - Guangdong Provincial Hospital of Chinese Medicine